Contraceptive patch, ring increase risk of thrombosis Epidemiology population study 12 January 2013 Pages: 1 - 1
The US FDA has made updates to the Revlimid [lenalidomide] label, similar to those announced recently by Health Canada.* News item 12 January 2013 Pages: 2 - 2
The Canadian label for Benlysta [belimumab] has been updated to warn about the associated risks of hypersensitivity and infusion reactions. News item 12 January 2013 Pages: 2 - 2
FDA issues new contraindications for fingolimod following death News item 12 January 2013 Pages: 2 - 2
The antihypertensives Aceon [perindopril], Altace [ramipril] and Atacand [candesartan cilexetil] were all issued boxed warnings by the US FDA in April 2012. News item 12 January 2013 Pages: 2 - 2
Increased risk of squamous cell carcinoma with voriconazole Clinical study 12 January 2013 Pages: 3 - 3
RE-LY: low risk of intracranial haemorrhage with dabigatran Clinical study 12 January 2013 Pages: 3 - 3
A study conducted in India showed that sublingual immunotherapy is safe during pregnancy Clinical study 12 January 2013 Pages: 4 - 4
Increased risk of uveitis and scleritis with bisphosphonates Clinical study 12 January 2013 Pages: 4 - 4
Short-term ocular adverse effects with systemic isotretinoin Clinical study 12 January 2013 Pages: 4 - 4
Acetylcysteine/carisoprodol/hydrocodone/paracetamol overdose Case report 12 January 2013 Pages: 5 - 5
